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The impact of clinical, pathologic, and surgical variables on the postoperative morbidity, mortality, and survival of
patients undergoing extended resections of colon carcinoma were evaluated.
METHODS: The medical records of 95 patients who underwent extended resections for colon carcinoma between
1953 and 1996 were reviewed. In all cases, in addition to colectomy, 1 or more organs and/or structures were resected en bloc
due to a macroscopically based suspicion of tumor invasion. The clinical, pathologic, and surgical parameters were analyzed.
Overall survival rates were analyzed according to the method of Kaplan and Meier. Multivariate analysis was performed
using the Cox proportional hazards model.
RESULTS: Eighty-six patients were treated by curative surgeries and the remaining by palliative resections. Invasion
of the organs and/or adjacent structures and regional lymph nodes was found microscopically in 48 and 31 patients,
respectively. The median follow-up without postoperative mortality was 47.7 months. The 5-year overall survival rates was
52.6%. The 5-year overall survival rates for patients undergoing curative and palliative surgeries was 58.3% and 0%,
respectively. The mean survival time in the palliative surgery group was 3.1 months. Multivariate analysis showed that
Karnofsky performance status was strongly related to the risk of postoperative complications (P = .01), and postoperative
deaths were associated with the type of surgery and Karnofsky performance status at the time of admission (P = .001).
CONCLUSIONS: Some patients with locally advanced colon adenocarcinomas undergoing extended resections have
a 5-year overall survival rates of 58.3%. Patients could benefit from palliative-intent procedures, but these measures should
cautiously be indicated and avoided in patients with low Karnofsky performance status due to high rates of postoperative
mortality and poor survival.
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The term, locally advanced
colorectal cancer, refers to tumors in-
filtrating or adherent to adjacent or-
gans and/or structures in patients with-
out distant metastases. Frequently
considered an uncurable disease, lo-
cally advanced colorectal cancer rep-
resent 5% to 22% of all colorectal car-
cinomas.1-5
In the USA, there are an estimated
nearly 130,000 new cases per year of
colorectal carcinoma, and 6,500 cases
are locally advanced.6 Surgery still re-
mains the only curative treatment for
colon cancer. Radiation and chemo-
therapy do not cure locally advanced
colon cancer.7
Extended or multivisceral resec-
tion is the type of procedure in which,
in addition to the standard operation,
adherent organs and/or structures are
resected en bloc.8 The rational for
multivisceral resections is that micro-
scopic infiltration of the organs and/
or adjacent structures can not be ascer-
tained preoperatively or even
intraoperatively.9 Furthermore, the dis-
section between the colonic tumor and
the adjacent structures can seed
neoplastic cells in the peritoneal sur-
face, resulting in a poor progno-
sis.1,2,11,12 Thus, this practice should be
avoided.
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Extended surgeries are recom-
mended because good local control of
colorectal cancer can be achieved with
results for 5-year survival of rates of
33% to 79% in different series .2,8,11,13,14
Despite the good survival rates, pa-
tients undergoing extended resections
experience considerable postoperative
mortality and morbidity.3,13,15 With the
improvement of postoperative care and
surgical technique, postoperative mor-
tality and morbidity rates have de-
creased and are comparable to the rates
achieved with standard or nonextended
resections.11,16
The aim of this study was to evalu-
ate the clinical, pathologic, and surgi-
cal prognostic factors in patients with
locally advanced colon cancer treated
with surgery.
PATIENTS AND METHODS
The medical records of 95 patients
with locally advanced colon carci-
noma undergoing extended resections
from 1953 to 1996 were reviewed. Ex-
tended resection was defined as an en
bloc surgery of the primary colon
tumor together with 1 or more organs
and/or structures that are macroscopi-
cally adherent to the tumor-bearing
bowel segment. The presence of mac-
roscopic residual tumor (R2 resection),
positive microscopic margins (R1 re-
section), or abdominal or systemic dis-
ease indicated the palliative-intent
procedures. The absence of these ele-
ments (R0 resection) indicated the
curative-intent surgeries.
Clinical and laboratory variables
were studied, including age, gender,
Karnofsky performance status at ad-
mission, tumor location, preoperative
serum albumin, and hemoglobin level.
Surgical records were searched for
type of surgery (curative or palliative),
date of the procedure, previous
laparotomy, operative time, number of
resected organs and/or structures, hos-
pital stay, and decade of the surgery.
Data related to postoperative complica-
tions, as well as the date and cause of
death were also collected. All slides
were reviewed by the same pathologist.
Histological subtypes, tumor grade,
microscopic margins, clinical and
pathological stages (pTNM-1997), pri-
mary tumor penetration (pT), lymph
node status (pN), perineural infiltration,
and lymphatic and vascular emboliza-
tion were evaluated. The outcome was
classified as follows: alive with no evi-
dence of disease; dead by cancer or re-
lated causes, including treatment; dead
without cancer (causes not related); and
lost to follow-up. The specific cancer
mortality was evaluated. The survival
analysis began on the date of the sur-
gery and finished on June 30th 1999.
Postoperative deaths were those oc-
curred during the hospitalization or re-
admission due to short-term complica-
tions. We considered the case lost to
follow-up when the patient did not re-
turn within a time equal or longer than
2 times the recommended time interval.
Statistics
The chi-square and Fisher exact
tests were used to compare variables.
The multiple logistic regression model
was used to evaluate complications
and postoperative death risk. The ac-
tuarial survival estimates were calcu-
lated according to the Kaplan &
Meyer method, and the multifactorial
relative risk of death was analyzed
with the Cox proportional hazards
model using a significance level of P
<.05. A variable was selected for
multivariate analysis when P <.10.
Postoperative mortality was not ex-
cluded from the analysis. The SPSS®
program for WindowsTM 8.0 was used.
RESULTS
Five patients who had surgery dur-
ing the 1950s were evaluated, 7 with
surgery in the 1960s, 21 in 1970s, 35
in 1980s, and 27 in 1990s. Patient
ages ranged from 15 to 84 years (me-
dian = 56 years). Of the total of 95 pa-
tients, 48 were male and 86 were Cau-
casian. The disease evolution time
ranged from 1 day, for a patient with
an acute abdomen, to 60 months (mean
= 11.1 months). The cecum and sig-
moid were the most frequent tumor lo-
cations.
The most common signs and symp-
toms were pain (71), weight loss (69),
rectal bleeding (38), change in bowel
habits (52), tumor (53), mucorrhea (9),
fever (9), fistula (7), vaginal bleeding
(4), and pneumaturia (3). A palpable
tumor at the physical examination was
found in 57 patients. Seventy-one pa-
tients had no previous treatment, and
24 had been already undergone
laparotomy, with the tumor considered
unresectable. Curative surgery (R0)
was performed in 86 cases. The opera-
tive time ranged from 2 to 12.2 hours
(mean = 6 hours). Intra-operative blood
transfusion was necessary in 79 pa-
tients (mean = 900 mL). The hospital
stay ranged from 1 day (1 patient who
died during the surgery) to 70 days
(mean = 15.5; median = 11 days). The
number of organs and/or structures
resected en bloc was 1 (40 patients), 2
(38 patients); 3 (11 patients); 4 (5 pa-
tients), and 5 (1 patients). Abdominal
wall muscles were the most frequently
resected structures (36), followed by
the small bowel (29) and bladder (18).
Regarding the types of tumors
found, 61 patients had pure adenocar-
cinoma, 27 mucinous, and 7 other his-
tologic subtypes. Regarding tumor dif-
ferentiation, 21 were well differenti-
ated; 54 moderately differentiated, and
20 poorly differentiated.
Microscopic involvement of adja-
cent organs and/or structures occurred
in 48 patients. In 1 case, it was not pos-
sible to differentiate inflammatory ad-
hesion from tumor infiltration. The
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number of dissected lymph nodes
ranged from 3 to 72 nodes (mean =
21.4 nodes). In 6 cases, the lymph node
status could not be established. In 58
patients, lymph node metastasis was
absent (pN0).
The tumor penetration (pT) and
lymph node status (pN) parameters are
listed in Table 1. Table 2 shows the re-
lationship between resected organs
and/or structures and the histologic in-
filtration.
Twenty-two deaths occurred, and
morbidity related to extended resec-
tions was observed in 53 patients. The
main complications were cardiovascu-
lar (18), wound infection (16), intesti-
nal fistula (6), sepsis (6), deep venous
thrombosis (3), wall dehiscence (3), uri-
nary fistula (2), and hernia (2). Table 3
shows the relative risk of complication
and death according to selected vari-
ables. Karnofsky performance status (P
= .02) and type of surgery (curative vs
palliative) (P =.004) were independent
prognostic factors for postoperative
death rates in the multivariate analysis
(P =.001) (Table 3).
Patients treated after 1980 had
39% fewer postoperative complica-
tions. Postoperative mortality de-
creased from 42.9% in the 1950s to
7.4% in the 1990s (P =.09). The post-
operative death risk decreased 57% for
patients treated after 1980.
Patients who underwent palliative
surgeries had higher complication
rates (77.8% vs 53.5%) and postopera-
Table 2 - Resected organ and/or structure, tumor penetration, and 5-year overall
survival rates in patients undergoing extended resections due to colon cancer.
Resected organ and/ Number of Tumor penetration 5-year survival (%)
or structure patients  staging (pT4)
Abdominal wall 36 18 57.7
Small bowel 29 10 57.7
Bladder 18 6 54.2
Ovary 12 3 41.7
Uterus 10 6 37.5
Duodenum 8 2 56.2
Stomach 10 2 56.2
Kidney 6 2 83.3
Gonadal vessels 4 2 100.0
Pancreas 3 1 100.0
Liver 3 2 66.7
Prostate 1 0 0
Ureter 1 0 0
Total 95 48 -
Table 1 - Tumor penetration and lymph node status in patients undergoing extended resections due to colon cancer.
Tumor Penetration Lymph node Lymph node Lymph node Lymph node Lymph node
(pT) status (pN0) status (pN1) status (pN2) status (pNx) status (pN+) Total
pT2 3 - - - - 3
pT3 27 11 5 - 16 43
pT4 28 7 8 5 15 48
pTx - - - 1 - 1
Total 58 18 13 6 31 95
Table 3 - Relative risk of postoperative complication and death according to selected variables in patients undergoing
extended resections due to colon cancer.
Variable Category Number of Odds Complication P Odds Death P
patients ratio confidence ratio confidence
interval interval
Karnofsky performance status 80 to 100 41 1.00 ref .01 1.00 ref .02
60 to 70 48 2.82+ 1.22-6.54 1.44 0.50-4.15
< or = 50 0 6 9.71 1.48-63.80
Albumin* >or =3.5g% 23 1.00 ref .05 1.00 ref .82
<3.5g% 71 2.53 0.96-6.65 1.13 0.36-3.51
Pre-operative >= 10g% 54 1.00 ref .19 1.00 ref .08
Hemoglobin <10g% 41 1.73 0.76-3.97 2.32 0.88-6.14
Surgical status Intact 71 1.00 ref .21 1.00 ref .80
on admission Previous laparotomy 24 1.84 0.67-4.84 1.15 0.39-3.37
Type of Curative 86 1.00 ref .18 1.00 ref .004
surgery Palliative 9 3.04 0.60-15.50 8.75 1.97-38.76
Number of resected 1 40 1.00 ref .77 1.00 ref .71
organs 2 to 5 55 0.88 0.39-2.02 0.84 0.32-2.20
*Cases without information were excluded from analysis; + fair and bad association; ref = reference.
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tive death (66.7% vs 18.6%) compared
to curative procedures. The univariate
analysis showed that cardiopulmonary
complications (P =.001) and anasto-
mosis dehiscences with sepsis (P
=.009) were also related to high rates
of postoperative mortality.
The follow-up ranged from 1 to
295.2 months (mean = 53.9; median =
24.3 months). Excluding the postop-
erative deaths, the mean and median
follow-up were 69.7 and 47.7 months,
respectively. The status at the end of
the study was: 29 (30.5%) alive with-
out cancer, 26 (27.4%) deaths due to
cancer, 22 (23.2%) postoperative
deaths, 6 (6.3%) deaths due to causes
not related to cancer, 1 (1.1%) alive
with cancer, 1 (1.1%) death due to
cause not reported, and 10 (10.5%)
were lost to follow-up, with 2 of them
having recurrent disease. Thirty pa-
tients experienced recurrent disease
that was local (10), distant (17), or lo-
cal and distant (3). Eighty percent of
Figure 1 - Overall survival rate of patients with colon cancer undergoing extended resection.
the recurrences occurred within the
first 2 years after surgery.
The overall survival rate (OSR) at
5 and 10 years was 52.6% and 47.4%,
respectively (Figure 1). The mean and
median survival time for all the pa-
tients was 133.6 and 68.5 months re-
spectively. The mean survival time for
patients with vascular embolization
was 9.2 months (Figure 2). The 5-year
OSR for patients undergoing curative
surgeries was 58.3% (Figure 3). The
Table 4 shows the OSR according to
selected variables.
DISCUSSION
Colorectal carcinoma (CRC) is one
of the main causes of death in the
United States.6 Despite advances in
management, the rate of early diagno-
sis has not changed.17 Approximately
10% to 20% of CRC are advanced at
the time of diagnosis.13
Radiation and chemotherapy do
not cure CRC after incomplete resec-
tion.7 Surgery for recurrent CRC is
rarely successful. The failure in the
treatment of advanced CRC could be
avoided if extended resection were
considered in the first approach.15,19,20,21
Preoperative image tests could help
in predicting the absence or presence
of malignant invasion of contiguous
structures; however, these methods
should not be employed to contrain-
dicate laparotomy for advanced colon
cancer.10,14
Moyniham first reported in 1926
an extended resection for locally ad-
vanced CRC.22 The survival rates
achieved with en bloc resections are
significantly higher than those ob-
tained with operative separation of ad-
hesions.1,2,12 During the exploration of
the abdominal cavity, it is difficult to
differentiate inflammatory adhesions
from carcinomatous infiltration.23 Bi-
opsies and manipulation of adhesions
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Figure 2 - Overall survival rate according to vascular embolization (absent vs present) in patients undergoing extended resection for colon
cancer.
Figure 3 - Overall survival rate according to the type of surgery (curative vs. palliative) in patients undergoing extended resection for colon
cancer.
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can lead to intraperitoneal seeding of
tumoral cells. Hunter et al. had 69%
with local recurrence following resec-
tions with separation of adhesions and
18% following en bloc resections.1
The good results achieved in dif-
ferent studies regarding local control
of CRC and survival rates confirm that
en bloc multivisceral resections should
be the standard treatment of locally
advanced colon cancer for a selected
group of patients. Some studies com-
paring extended and classic surgeries
found that the presence of positive
margins was associated with poor sur-
vival rates.8,16,24 There is no 5-year sur-
vival when palliative surgery is per-
formed.3,5,11,14,16
In this series we found several patho-
logical characteristics that were related
to a better prognosis for CRC, such as
48.4% of inflammatory adhesions;
61.1% of non metastatic lymph nodes;
78.9% of grade I and II tumors; 73.7%
of absence of vascular embolization;
78.9% of absence of perineural infiltra-
tion and 62.1% absence of lymphatic
embolization. Tumor penetration (pT)
and the lymph node status (pN) are the
most evaluated prognostic factors in sev-
eral reported series of locally advanced
CRC. Lymph node metastasis4,10,25 and
adjacent organ infiltration4,5 have been
identified as poor prognostic factors;
however, there is not a consensus on this
finding.15,16 On the other hand, there is
consensus that positive surgical mar-
gins24,26,27 and nonextended resections
for patients with pT4 tumors11,16,27 are
strongly related to a poor prognosis.
The survival analysis based on
each resected organ (Table 2) is diffi-
cult due to the high degree of associa-
tion of resected organs and/or struc-
tures,4 but there was no statistically
significant difference in the survival of
patients undergoing en bloc resection
of 1 organ compared to those that had
2 or 5 resected organs, showing as in
other series that the involvement of
several organs should not be a con-
traindication for surgery.11
The significant decrease of postop-
erative complications and death rates
from the 1950s to 1990s could be at-
tributed to the improvement in staging
methods, preoperative and postopera-
tive care, intensive care, and the expe-
rience of surgical team. Patients under-
going surgery after 1980s had a more
than 50% decrease in the chance of
death related to the procedure as com-
pared to those undergoing surgery in
the early 1950s. Our data support that
the experience gained with extended
resections plays an important role in
the outcome of patients with locally
advanced CRC.
Curative extended resections are
the best treatment for patients with lo-
cally advanced colon cancer. Some pa-
tients could benefit from palliative-in-
tent procedures, but these should cau-
tiously be indicated in patients with
low Karnofsky performance status due
to high rates of postoperative mortal-
ity and poor survival.
Table 4 - Five year overall survival rate according to selected variables in patients
undergoing extended resection due to colon cancer.
Variable Category No. of 5-year overall P
patients survival rates (%)
Type of surgery Curative 86 58.3 <.001
Palliative 9 0
pT stage* pT2+3 46 63.4 .02
pT4 48 41.3
Lymph node Absent 58 57.5 .72
 metastasis Present 31 44.1
Ignored 6 44.4
EC (TNM) I + II 55 57.6 .16
III 26 52.8
IV 7 14.3
Ignored 7 53.2
Differentiation Well 21 42.6 .33
Moderate 54 57.7
Poor 20 47.5
Adenocarcinoma Pure 61 61.2 .08
 subtype Mucinous 27 39.4
Other 7 28.6
Vascular Absent 70 61.6 .0002
 embolization Present 25 27.4
Lymphatic vessel Absent 59 60.0 .04
 embolization Present 36 40.2
Perineural Absent 75 55.9 .07
 infiltration Present 20 40.4
* = one case excluded for analysis.
RESUMO
VIEIRA RAC e col. Fatores prognósti-
cos em câncer de cólon localmente
avançado tratado com ressecção
extendida. Rev. Hosp. Clín. Fac.
Med. S. Paulo 59(6):361-368, 2004.
Foi avaliado o impacto de variáveis
clínicas, patológicas e cirúrgicas na
morbidade e mortalidade pós operató-
rias de pacientes submetidos à ressecção
extendida de carcinoma do cólon.
MÉTODOS: Prontuários médicos
de 95 pacientes submetidos á ressecção
extendida de carcinoma de cólon entre
os anos de 1953 e 1996 foram revisa-
dos. Em todos os casos, além de
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